Emerald Health Therapeutics Closes $2.5 Million Prospectus Sale and Concurrent Secondary Sale

Emerald Health Therapeutics Closes .5 Million Prospectus Sale and Concurrent Secondary Sale

Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), announced today that it closed its prospectus sale (the “Offering”) to a single Canadian institutional accredited investor (the “Investor”), as announced on November 13, 2019. Each Unit consists of one common share of Emerald (each, a “Common Share”) and one common share purchase warrant (each, a “Warrant”). READ MORE: https://finance.yahoo.com/news/emerald-health-therapeutics-closes-2-020631244.html?.tsrc=rss The post Emerald Health Therapeutics Closes $2.5 Million Prospectus Sale and Concurrent Secondary Sale appeared first on Cannabis Daily.

Excerpt only …
READ MORE BELOW
Source : New feed
Link to original : Emerald Health Therapeutics Closes .5 Million Prospectus Sale and Concurrent Secondary Sale
reposted by Cannabis News World

Advertisements

This site uses Akismet to reduce spam. Learn how your comment data is processed.